Alvotech And Finesse Solutions Announce Exciting Bio-Manufacturing Collaboration
3/13/2014 9:52:33 AM
REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. today announced that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient manufacturing and laboratory technology through the Finesse turnkey SmartFactory® GMP manufacturing platform suite. SmartFactory® is a single-use cGMP bio-manufacturing capacity, which will allow Alvotech to rapidly expand its biosimilars business. Finesse’s customers will benefit from unprecedented access to Alvogen’s commercial, FDA approved, biomanufacturing facility.
Help employers find you! Check out all the jobs and post your resume.
comments powered by